The study is looking at patients with primary sclerosing cholangitis and co-existant inflammatory bowel disease. research hub

The use of CARBALIVE in the treatment of cholestatic liver disease

This study is for people in the UK with a liver condition called primary sclerosing cholangitis and inflammatory bowel disease. It tests a new treatment called CARBALIVE to see if it's safe and helps improve health by stopping harmful gut bacteria from damaging the liver.